Factive tab. approved by KFDA as the fifth new drug in Korea

The Korea Foood and Drug Administration (KFDA) said on December 27 that it approved LG Life Sciences's Factive tab.(gemifloxacin), a novel fluoroquinolone antibiotic with potent, broad-spectrum antimicrobial activity.

This was the fifth new drug approval by the KFDA, following SK Pharm's Sunpla inj., Dongwha's milican inj., Daewoong's EGF topical solution, and Choong-wae's Q-roxin tab.

Th...